HEPATITIS CAUSED BY THE NEWER AMINE-OXIDASE-INHIBITING DRUGS
Authors:
- C.D. HoldsworthCHC.D. Holdsworth
- Michael AtkinsonMAMichael Atkinson
- William GoldieWGWilliam Goldie
- 1 September 1961
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 278 (7203) , 621-623
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Trial a New Monoamine Oxidase Inhibitor in Angina PectorisBMJ, 1960
- Hepatocellular Jaundice as a Complication of Iproniazid TherapyArchives of internal medicine (1960), 1960
- FATAL JAUNDICE AFTER ADMINISTRATION OF BETA-PHENYLISOPROPYLHYDRAZINEJAMA, 1959
- SERIAL HEPATIC STUDY IN PATIENTS TREATED WITH IPRONIAZIDAnnals of the New York Academy of Sciences, 1959
- EXPERIMENTAL PATHOLOGY OF IPRONIAZID AND RELATED COMPOUNDSAnnals of the New York Academy of Sciences, 1959
- THE EFFECTS OF IPRONIAZID AND OTHER AMINE OXIDASE INHIBITORS IN RHEUMATOID ARTHRITISAnnals of the New York Academy of Sciences, 1959
- ACUTE HEPATIC NECROSIS FOLLOWING IPRONIAZID THERAPYThe Lancet, 1959
- PATHOLOGICAL FINDINGS IN JAUNDICE ASSOCIATED WITH IPRONIAZID THERAPYJAMA, 1958
- Use of Iproniazid in Ischaemic Angina PectorisBMJ, 1958